ASC Therapeutics
PrivateCompany Overview
ASC Therapeutics is a biotechnology company that develops gene replacement, gene editing, and allogeneic cell therapies for hematological, metabolic, and other rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
gene therapygene editingcell therapybiotechadeno-associated virusAAVhemophilia A treatmentrare diseasegenetic medicinein-vivo gene editingallogeneic cell therapyclinical-stage biotechdrug discoveryprecision medicinegraft-versus-host disease
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ASC Therapeutics Comparables
Compare ASC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sangamo Therapeutics Inc | 83% | |
| Expression Therapeutics, Inc. | 81% | |
| Ultragenyx Pharmaceutical Inc. | 79% | |
ASC Therapeutics Funding Rounds
Historical fundraising activity
ASC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ASC Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersMilpitas, California
Employee Range11
Year Founded2019
Last Funding—